dapsone has been researched along with Adverse Drug Event in 12 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recognition and timely adequate treatment of erythema multiforme remain a major challenge." | 2.58 | Current Perspectives on Erythema Multiforme. ( Harr, T; Lerch, M; Mainetti, C; Terziroli Beretta-Piccoli, B, 2018) |
| " Dapsone-related adverse events were mild and promptly reversed by treatment withdrawal." | 1.35 | Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura. ( Annichino-Bizzacchi, JM; De Paula, EV; Fabri, DR; Orsi, FL; Ozelo, MC; Vancine-Califani, SM, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dawson, S | 1 |
| Stahl, S | 1 |
| Paul, N | 1 |
| Barber, J | 1 |
| Kenna, JG | 1 |
| Liu, Z | 1 |
| Shi, Q | 1 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Fang, H | 1 |
| Tong, W | 1 |
| Sakatis, MZ | 1 |
| Reese, MJ | 1 |
| Harrell, AW | 1 |
| Taylor, MA | 1 |
| Baines, IA | 1 |
| Chen, L | 1 |
| Bloomer, JC | 1 |
| Yang, EY | 1 |
| Ellens, HM | 1 |
| Ambroso, JL | 1 |
| Lovatt, CA | 1 |
| Ayrton, AD | 1 |
| Clarke, SE | 1 |
| Morgan, RE | 1 |
| van Staden, CJ | 1 |
| Chen, Y | 1 |
| Kalyanaraman, N | 1 |
| Kalanzi, J | 1 |
| Dunn, RT | 1 |
| Afshari, CA | 1 |
| Hamadeh, HK | 1 |
| Baroudi, B | 1 |
| Bashyam, AM | 1 |
| Feldman, SR | 1 |
| Pichardo, RO | 1 |
| Lerch, M | 1 |
| Mainetti, C | 1 |
| Terziroli Beretta-Piccoli, B | 1 |
| Harr, T | 1 |
| Vancine-Califani, SM | 1 |
| De Paula, EV | 1 |
| Ozelo, MC | 1 |
| Orsi, FL | 1 |
| Fabri, DR | 1 |
| Annichino-Bizzacchi, JM | 1 |
| Biswas, SK | 1 |
| Coleman, MD | 1 |
| Larsen, FG | 1 |
| Larsen, CG | 1 |
| Brodersen, R | 1 |
| Tingle, MD | 1 |
| Park, BK | 1 |
| Weber, WW | 1 |
| Hein, DW | 1 |
2 reviews available for dapsone and Adverse Drug Event
| Article | Year |
|---|---|
Current Perspectives on Erythema Multiforme.
Topics: Acyclovir; Dapsone; Drug-Related Side Effects and Adverse Reactions; Erythema Multiforme; Herpes Sim | 2018 |
N-acetylation pharmacogenetics.
Topics: Acebutolol; Acetyl Coenzyme A; Acetylation; Acetyltransferases; Aminoglutethimide; Animals; Anti-Anx | 1985 |
10 other studies available for dapsone and Adverse Drug Event
| Article | Year |
|---|---|
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters | 2012 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2013 |
Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series.
Topics: Adalimumab; Dapsone; Drug-Related Side Effects and Adverse Reactions; Hidradenitis Suppurativa; Huma | 2023 |
Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Cohort Studies; Dapsone; Drug-Related Side Effects and Adverse Reactions; F | 2008 |
Chemotherapy of leprosy.
Topics: Anti-Bacterial Agents; Clofazimine; Dapsone; Dose-Response Relationship, Drug; Drug Combinations; Dr | 2004 |
Improvement of patient tolerance to dapsone: current and future developments.
Topics: Antioxidants; Cimetidine; Dapsone; Dermatologic Agents; Drug-Related Side Effects and Adverse Reacti | 2007 |
[Prevention of kernicterus. Current methods of determining drug-induced bilirubin displacement].
Topics: Albumins; Bilirubin; Dapsone; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infan | 1983 |
The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias.
Topics: Animals; Dapsone; Drug-Related Side Effects and Adverse Reactions; Erythrocyte Count; Hematologic Di | 1993 |